Locatelli, Franco http://orcid.org/0000-0002-7976-3654
Zugmaier, Gerhard http://orcid.org/0000-0001-6879-2671
Rizzari, Carmelo http://orcid.org/0000-0002-4828-3893
Morris, Joan D.
Gruhn, Bernd http://orcid.org/0000-0003-1862-0075
Klingebiel, Thomas http://orcid.org/0000-0001-5726-9092
Parasole, Rosanna
Linderkamp, Christin
Flotho, Christian
Petit, Arnaud http://orcid.org/0000-0001-8363-1622
Micalizzi, Concetta
Zeng, Yi
Desai, Rajendra
Kormany, William N.
Eckert, Cornelia
Möricke, Anja
Sartor, Mary
Hrusak, Ondrej
Peters, Christina http://orcid.org/0000-0003-0369-8515
Saha, Vaskar http://orcid.org/0000-0002-2916-9649
Vinti, Luciana
von Stackelberg, Arend
Article History
Received: 26 August 2022
Revised: 15 November 2022
Accepted: 17 November 2022
First Online: 8 December 2022
Competing interests
: FL reports advisory board membership for Amgen, Novartis, Bellicum Pharmaceuticals, Neovii, Vertex, and is on the Speakers’ Bureau for Amgen, Novartis, Miltenyi, Medac, Jazz Pharmaceuticals, and Takeda, outside the submitted work. GZ, JDM, YZ, and WNK are employed by Amgen. GZ has patents 20190300609 and 20130323247 licensed. CR reports personal fees from Amgen, Jazz Pharmaceuticals, Sobi, and grants and personal fees from Shire and Medac, outside the submitted work. RD supports Amgen as an employee of IQVIA. AM reports grants from Amgen during the conduct of the study and personal fees from Shire, outside the submitted work. CP reports membership on board of directors or advisory committee for Amgen, and travel support from Amgen, Neovii, Jazz, and Novartis, and Speakers’ Bureau for Riemser, Amgen, Novartis, and Medac. VS reports personal fees from Amgen during the conduct of the study. AvS reports personal fees from Amgen, Shire, Jazz, Roche, and MorphoSys, outside the submitted work. RP reports advisory board membership for Amgen, Novartis, and Shire and is on the Speakers’ Bureau for Jazz, Servier, and Amgen. BG, TK, CL, CF, AP, CM, CE, MS, OH, and LV have no disclosures.